Pluribus Labs’s Taylor Morrison TMHC Stock Holding History

Pluribus Labs’s Portfolio TMHC Stock Details TMHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,981	Closed	-$559K	–	206
2021 Q4	$559K	Buy	+15,981	New	+$499K	0.59%	37

Other funds holding TMHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Pluribus Labs's TMHC Position: Q1 2022 in Review

Pluribus Labs sold out of Taylor Morrison (TMHC) in Q1 2022, closing a stake of 15,981 shares — an estimated $559K sold.

Pluribus Labs first reported a position in TMHC in Q4 2021 and held it in 1 quarter. The position peaked at $559K in Q4 2021. 281 funds tracked by Wall St. Rank hold TMHC as of Q1 2022.

Pluribus Labs reported no remaining Taylor Morrison position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 15,981 Taylor Morrison shares in Q1 2022, an estimated $559K.
Pluribus Labs first reported a position in Taylor Morrison in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Taylor Morrison position peaked at $559K in Q4 2021.
281 funds tracked by Wall St. Rank held Taylor Morrison as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.